Renal Cancer
Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: A single-center study in Turkey - Abstract
December 15, 2011
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma - Abstract
December 14, 2011
Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2 - Abstract
December 14, 2011
A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23 - Abstract
December 13, 2011
A rare case of synchronous adrenocortical carcinoma and renal cell carcinoma - Abstract
December 13, 2011
Nutlin-3 enhances sorafenib efficacy in renal cell carcinoma - Abstract
December 12, 2011
Saturable absorption of sorafenib in patients with solid tumors: A population model - Abstract
December 12, 2011
Two different types of infantile renal cell carcinomas associated with tuberous sclerosis - Abstract
December 8, 2011
Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival - Abstract
December 7, 2011
Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma - Abstract
December 7, 2011
MDCT patterns of presentation of pancreatic metastases from renal cell carcinoma - Abstract
December 7, 2011
Sarcomatoid renal cell carcinoma is an example of epithelial-mesenchymal transition - Abstract
December 6, 2011
Risk factor for clear cell renal cell carcinoma in Chinese population: A case-control study - Abstract
December 6, 2011
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma - Abstract
December 6, 2011
The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma - Abstract
December 5, 2011
Ablative therapies in renal cell carcinoma - Abstract
December 2, 2011